Piper Jaffray Raises Price Target as Abiomed's (ABMD) Results Fall In-line with Preliminary Release

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. DOL:CN

Go back to Piper Jaffray Raises Price Target as Abiomed's (ABMD) Results Fall In-line with Preliminary Release

Abiomed Announces Q3 FY 2016 Revenue of $85.8 Million, Up 38% Over Prior Year

February 4, 2016 7:00 AM EST

U.S. Patient Utilization Grew 45%, Year Over Year Abiomed Increases Fiscal Year 2016 Revenue Guidance

DANVERS, Mass., Feb. 04, 2016 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today reported third quarter fiscal 2016 revenue of $85.8 million, an increase of 38% compared to revenue of $62.0 million for the same period of... More